SEARCH HEALTH CONDITIONS BY ALPHABETS
Acute Promyelocytic Leukemia
Medications for Acute Promyelocytic Leukemia
Other names: Cancer, Acute Promyelocytic Leukemia; Leukemia, Acute Promyelocytic
About Acute Promyelocytic Leukemia: Leukemia presenting because of severe bleeding disorder, with infiltration of the bone marrow by unusual promyelocytes and myelocytes, a minimal plasma fibrinogen, and defective coagulation.
Drugs Used to Treat Acute Promyelocytic Leukemia
The following set of medications have been somehow associated with, or utilized at the treating this illness.
| Medication title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| tretinoin | Rx | D | N | 3 testimonials | 9.0 | ||
Generic title: tretinoin systemic Brand title: Vesanoid Medication class: amalgamated antineoplastics For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Vesanoid | Rx | D | N | 1 inspection | 8.0 | ||
Generic title: tretinoin systemic Medication class: amalgamated antineoplastics For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| Trisenox | Rx | D | N | Insert inspection | 0.0 | ||
Generic title: arsenic trioxide systemic Medication class: amalgamated antineoplastics For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| arsenic trioxide | Rx | D | N | 1 inspection | 9.0 | ||
Generic title: arsenic trioxide systemic Brand title: Trisenox Medication class: amalgamated antineoplastics For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
Legend
| Rx | Prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Tag | This medication Might Not Be approved by the FDA for treating this illness. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus within the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal reproduction studies have demonstrated a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with used in elderly women clearly outweigh potential rewards. |
| N | FDA has not classified this medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | isn`t at the mercy of the Controlled Substances Act. |
| 1 | features a high potential for misuse. Has no currently accepted medical use in treatment in the USA. There is a lack of accepted safety for use under medical supervision. |
| Two | features a high potential for misuse. Features a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Abuse may lead to acute psychological or physical dependence. |
| 3 | Has a potential for abuse less than those in programs 1 and 2. Features a currently accepted medical use in treatment in the USA. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | features a minimal potential for abuse relative to those in program 3. It`s a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to those in program 3. |
| 5 | features a minimal potential for abuse relative to those in program 4. Features a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to those in program 4. |
| Infection | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always ask your physician to ensure the information applies to a personal circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
